| Mon, Nov 30, 2009 | | • | Research Firm Lays Out Surprise Bio Events for 2010: BioBuzz
at TheStreet.com (Mon 11:16am)
| | • | UPDATE - FDA holds up Merck KGaA's multiple sclerosis pill
at Reuters (Mon 9:58am)
| | Fri, Nov 27, 2009 | | • | Biotech Bargains for Your Portfolio
at Motley Fool (Fri, Nov 27)
| | Thu, Nov 26, 2009 | | • | Financing Drug Discovery: Recent Deals
at Seeking Alpha (Thu, Nov 26)
| | Wed, Nov 25, 2009 | | • | Cancer drug preserves insulin cells in diabetes
at Reuters (Wed, Nov 25)
| | • | Still Enjoying Those Acquisitions, Pfizer?
at Motley Fool (Wed, Nov 25)
| | • | InvestorSoup.com Issues Technical Trading Outlook for ARCA biopharma Inc.
GlobeNewswire (Wed, Nov 25)
| | Mon, Nov 23, 2009 | | • | [$$] Fitz Bits: Wait for a Retest in Ford
at RealMoney by TheStreet.com (Mon, Nov 23)
| | • | A Big Upgrade for Allos Therapeutics
at Motley Fool (Mon, Nov 23)
| | • | Icahn Makes Big Moves in Healthcare Stocks
Indie Research (Mon, Nov 23)
| | Sun, Nov 22, 2009 | | • | Spectrum Pharma: Zevalin Sales Ramp Up
at Seeking Alpha (Sun, Nov 22)
| | Fri, Nov 20, 2009 | | • | UPDATE - HealthCor slams Biogen CEO for outsize pay package
at Reuters (Fri, Nov 20)
| | • | Uncertainty Breeds Opportunity in Specialty Pharma Stock Pick From Piper Jaffray Senior Research Analyst
Wall Street Transcript (Fri, Nov 20)
| | • | Biogen's Rituxan Label Expansion Delayed
Zacks.com (Fri, Nov 20)
| | Thu, Nov 19, 2009 | | • | This Stock Is a Train Wreck
at Motley Fool (Thu, Nov 19)
| | Wed, Nov 18, 2009 | | • | Genentech, Biogen get FDA request on Rituxan
AP (Wed, Nov 18)
| | Tue, Nov 17, 2009 | | • | [$$] Activity Jumps in Biotech and Drug Firms
at The Wall Street Journal Online (Tue, Nov 17)
| | • | Genzyme's Termeer: Worst Biotech CEO of '09
at TheStreet.com (Tue, Nov 17)
| | Fri, Nov 13, 2009 | | • | Abbott: Brave or Stupid?
at Motley Fool (Fri, Nov 13)
| | Thu, Nov 12, 2009 | | • | Wider Loss for Alnylam
Zacks.com (Thu, Nov 12)
|
Add BIIB News to My Yahoo!:
 
| |
|
0.34% Nasdaq 0.00%
Headlines
